Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12643428 | 1.00 | TDP1 (0.47) | TDP1RAB9ANPC1GAAMAPT | |
| SCHEMBL12113871 | 0.99 | TDP1 (0.46) | TDP1RAB9ANPC1GAAMAPT | |
| SCHEMBL12112450 | 0.99 | TDP1 (0.46) | TDP1RAB9ANPC1GAAMAPT | |
| SCHEMBL12586965 | 0.99 | TDP1 (0.46) | TDP1RAB9ANPC1GAAMAPT | |
| SCHEMBL12354563 | 0.96 | TDP1 (0.45) | TDP1RAB9ANPC1GAAMAPT | |
| SCHEMBL12362249 | 0.96 | TDP1 (0.45) | TDP1RAB9ANPC1GAAMAPT | |
| SCHEMBL12587117 | 0.90 | KDM1A (0.41) | TDP1RAB9ANPC1GAAMAPT | |
| SCHEMBL12587047 | 0.85 | SMN1; SMN2 (0.41) | TDP1GAAMAPTLMNAKDM1A | |
| SCHEMBL16572032 | 0.85 | CYP1A2 (0.52) | TDP1RAB9ANPC1GAAMAPT | |
| SCHEMBL12587020 | 0.80 | TDP1 (0.49) | TDP1RAB9ANPC1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7968156-B2 | Compound, composition, retardation plate, elliptically-polarizing plate and liquid-crystal display device | FUJIFILM CORPORATION (JP) | 2011-06-28 | — | — | US | disclosed |
| US-7968157-B2 | Discotic nematic material, composition, retardation plate, elliptically-polarizing plate and compound | FUJIFILM CORPORATION (JP) | 2011-06-28 | — | — | US | disclosed |
| US-20090233009-A1 | COMPOUND, COMPOSITION, RETARDATION PLATE, ELLIPTICALLY-POLARIZING PLATE AND LIQUID-CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20090068378-A1 | DISCOTIC NEMATIC MATERIAL, COMPOSITION, RETARDATION PLATE, ELLIPTICALLY-POLARIZING PLATE AND COMPOUND | FUJIFILM CORPORATION (JP) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068378-A1 | DISCOTIC NEMATIC MATERIAL, COMPOSITION, RETARDATION PLATE, ELLIPTICALLY-POLARIZING PLATE AND COMPOUND | H1-2, H1-0, CCNL2 | TDP1 2318/4885RAB9A 1669/4885NPC1 1265/4885 |
| US-20090233009-A1 | COMPOUND, COMPOSITION, RETARDATION PLATE, ELLIPTICALLY-POLARIZING PLATE AND LIQUID-CRYSTAL DISPLAY DEVICE | PYM1, CCNA1, CCND1 | TDP1 3752/4885RAB9A 2026/4885NPC1 4680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.